BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37870468)

  • 41. SIP1 mediates cell-fate decisions between neuroectoderm and mesendoderm in human pluripotent stem cells.
    Chng Z; Teo A; Pedersen RA; Vallier L
    Cell Stem Cell; 2010 Jan; 6(1):59-70. PubMed ID: 20074535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A component of the ARC/Mediator complex required for TGF beta/Nodal signalling.
    Kato Y; Habas R; Katsuyama Y; Näär AM; He X
    Nature; 2002 Aug; 418(6898):641-6. PubMed ID: 12167862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Regulatory Network Involving β-Catenin, e-Cadherin, PI3k/Akt, and Slug Balances Self-Renewal and Differentiation of Human Pluripotent Stem Cells In Response to Wnt Signaling.
    Huang TS; Li L; Moalim-Nour L; Jia D; Bai J; Yao Z; Bennett SA; Figeys D; Wang L
    Stem Cells; 2015 May; 33(5):1419-33. PubMed ID: 25538040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exogenous supplementation of Activin A enhances germ cell differentiation of human embryonic stem cells.
    Duggal G; Heindryckx B; Warrier S; Taelman J; Van der Jeught M; Deforce D; Chuva de Sousa Lopes S; De Sutter P
    Mol Hum Reprod; 2015 May; 21(5):410-23. PubMed ID: 25634576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activin/nodal signaling and NANOG orchestrate human embryonic stem cell fate decisions by controlling the H3K4me3 chromatin mark.
    Bertero A; Madrigal P; Galli A; Hubner NC; Moreno I; Burks D; Brown S; Pedersen RA; Gaffney D; Mendjan S; Pauklin S; Vallier L
    Genes Dev; 2015 Apr; 29(7):702-17. PubMed ID: 25805847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic and pharmacological control of pigmentation via Bromodomain Protein 9 (BRD9).
    Basuroy T; Dreier M; Baum C; Blomquist T; Trumbly R; Filipp FV; de la Serna IL
    Pigment Cell Melanoma Res; 2023 Jan; 36(1):19-32. PubMed ID: 36112085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential response of epiblast stem cells to Nodal and Activin signalling: a paradigm of early endoderm development in the embryo.
    Kaufman-Francis K; Goh HN; Kojima Y; Studdert JB; Jones V; Power MD; Wilkie E; Teber E; Loebel DA; Tam PP
    Philos Trans R Soc Lond B Biol Sci; 2014 Dec; 369(1657):. PubMed ID: 25349457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Role of SMAD2/3 in Human Embryonic Stem Cells.
    Yang J; Jiang W
    Front Cell Dev Biol; 2020; 8():653. PubMed ID: 32850796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activin/nodal signaling switches the terminal fate of human embryonic stem cell-derived trophoblasts.
    Sarkar P; Randall SM; Collier TS; Nero A; Russell TA; Muddiman DC; Rao BM
    J Biol Chem; 2015 Apr; 290(14):8834-48. PubMed ID: 25670856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway.
    Vallier L; Reynolds D; Pedersen RA
    Dev Biol; 2004 Nov; 275(2):403-21. PubMed ID: 15501227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogramming.
    Sevinç K; Sevinç GG; Cavga AD; Philpott M; Kelekçi S; Can H; Cribbs AP; Yıldız AB; Yılmaz A; Ayar ES; Arabacı DH; Dunford JE; Ata D; Sigua LH; Qi J; Oppermann U; Onder TT
    Stem Cell Reports; 2022 Dec; 17(12):2629-2642. PubMed ID: 36332631
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of embryonic stem cell self-renewal and differentiation by TGF-beta family signaling.
    Fei T; Chen YG
    Sci China Life Sci; 2010 Apr; 53(4):497-503. PubMed ID: 20596917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activin and BMP4 synergistically promote formation of definitive endoderm in human embryonic stem cells.
    Teo AK; Ali Y; Wong KY; Chipperfield H; Sadasivam A; Poobalan Y; Tan EK; Wang ST; Abraham S; Tsuneyoshi N; Stanton LW; Dunn NR
    Stem Cells; 2012 Apr; 30(4):631-42. PubMed ID: 22893457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NKX2-1 activation by SMAD2 signaling after definitive endoderm differentiation in human embryonic stem cell.
    Li Y; Eggermont K; Vanslembrouck V; Verfaillie CM
    Stem Cells Dev; 2013 May; 22(9):1433-42. PubMed ID: 23259454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells.
    James D; Levine AJ; Besser D; Hemmati-Brivanlou A
    Development; 2005 Mar; 132(6):1273-82. PubMed ID: 15703277
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours.
    Chen Y; Gao Z; Mohd-Ibrahim I; Yang H; Wu L; Fu Y; Deng Y
    Clin Transl Med; 2024 Feb; 14(2):e1543. PubMed ID: 38303608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activin-Nodal signaling is involved in propagation of mouse embryonic stem cells.
    Ogawa K; Saito A; Matsui H; Suzuki H; Ohtsuka S; Shimosato D; Morishita Y; Watabe T; Niwa H; Miyazono K
    J Cell Sci; 2007 Jan; 120(Pt 1):55-65. PubMed ID: 17182901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of activin A supplementation during human embryonic stem cell derivation on germ cell differentiation potential.
    Duggal G; Heindryckx B; Warrier S; O'Leary T; Van der Jeught M; Lierman S; Vossaert L; Deroo T; Deforce D; Chuva de Sousa Lopes SM; De Sutter P
    Stem Cells Dev; 2013 Dec; 22(23):3141-55. PubMed ID: 23829223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patterning of mouse embryonic stem cell-derived pan-mesoderm by Activin A/Nodal and Bmp4 signaling requires Fibroblast Growth Factor activity.
    Willems E; Leyns L
    Differentiation; 2008 Sep; 76(7):745-59. PubMed ID: 18177426
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy.
    Lonardo E; Hermann PC; Mueller MT; Huber S; Balic A; Miranda-Lorenzo I; Zagorac S; Alcala S; Rodriguez-Arabaolaza I; Ramirez JC; Torres-Ruíz R; Garcia E; Hidalgo M; Cebrián DÁ; Heuchel R; Löhr M; Berger F; Bartenstein P; Aicher A; Heeschen C
    Cell Stem Cell; 2011 Nov; 9(5):433-46. PubMed ID: 22056140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.